Series C - Evariant
Investment Firm
Overview
Evariant enables providers to optimize growth through smarter patient acquisition and retention.
Announced Date
May 10, 2016
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
Goldman Sachs
Goldman Sachs is a debt and early_stage_venture and late_stage_venture and private_equity and seed firm.
McKesson Ventures
McKesson Ventures is a early_stage_venture and late_stage_venture and private_equity and venture firm.
Salesforce Ventures
Salesforce Ventures is a convertible_note and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.
Participant Investors
5
Round Details and Background
Evariant raised an undisclosed amount on 2016-05-10 in Series C
Evariant enables providers to optimize growth through smarter patient acquisition and retention.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 02, 2014 |  Series B - Evariant | 2 | - | 18.3M |
| Feb 27, 2014 | Debt Financing - Evariant | - | 1.5M | |
| Jun 01, 2012 | Venture Round - Evariant | - | 2.6M | |
| Nov 21, 2011 | Series A - Evariant | 1 | - | 5.3M |
Recent Activity
There is no recent news or activity for this profile.